Zhengye Biotechnology Holding (ZYBT) Current Leases (2025)

Zhengye Biotechnology Holding (ZYBT) reported Current Leases of $14945.2 for Q4 2025.

Zhengye Biotechnology Holding (ZYBT) Current Leases (2025) Analysis & Trends

Zhengye Biotechnology Holding (ZYBT) has 1 years of Current Leases data on file, last reported at $14945.2 in Q4 2025.

  • Current Leases for Q4 2025 came in at $14945.2, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $14945.2 (changed N/A YoY), and the FY2025 annual result was $15000.0, changed N/A from the prior year.
  • Current Leases steadied at $14945.2 in Q4 2025 per ZYBT's latest filing.
  • Over five years, Current Leases peaked at $14945.2 in Q4 2025 and troughed at $14945.2 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn -
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 23.81 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 7.58 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 5.58 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -
10 Zhengye Biotechnology Holding 5.49 Mn 6.20 Mn - 14,945.22

Historic Data

Download Data
DateValue
Dec 31, 2025 14,945.22